You are on page 1of 3

Dr. Sadiqa Stelzner, M.D.

, FACS is Honored by the Top 100 Registry as a Top


100 Doctor in the Field of Ophthalmology

Dr. Sadiqa Stelzner, M.D., FACS is due to be featured in the Top 100 Doctors Magazine, 2022 Q2
Edition, and is being honored by the Top 100 Registry as the 2022 Doctor of the Year in the State of
California.

Santa Monica, CA February 23, 2022 --(PR.com)-- Dr. Sadiqa Stelzner, M.D., FACS, is a board-certified
ophthalmologist with Santa Monica Eye Medical Group, Santa Monica, California. As an educator and a
leader in innovative eye surgical techniques and laser surgeries, Dr. Stelzner is the Chief Physician at the
Santa Monica Eye Group. She specializes in cataract, refractive laser, esthetic, and eyelid surgeries. Dr.
Stelzner earned her undergraduate degree in Biochemistry and a graduate degree in Cellular and
Molecular Biology at UCLA. Then, she completed her medical degree at Boston University.
Subsequently, she concluded her ophthalmology residency at the University of Washington in Seattle and
worked with Dr. David McIntyre at an internationally renowned private practice. In addition, Dr. Stelzner
completed executive management training at the Yale School of Management. Her vast knowledge,
extensive experience, and compassion for her patients have made her one of the top ophthalmologists in
the country. In addition to her practice, Dr. Stelzner is Chief of Ophthalmology at the Santa
Monica-UCLA Medical Center and Orthopedic Hospital. She is also an Associate Clinical Professor at
the David Geffen School of Medicine/Jules Stein Eye Institute, where she attends the UCLA
Ophthalmology residents. Additionally, Dr. Stelzner is the benefactor of several UCLA undergraduate
and graduate scholarships. She is a staff surgeon at St. John’s Hospital in Santa Monica, Cedars-Sinai
Surgery Center of the Pacific, and Specialty Surgical Center of Beverly Hills, California.

As a result of her extensive knowledge and experience, Dr. Stelzner often researches, teaches, and
publishes many peer-reviewed articles in respected scientific journals. Notably, she received an invitation
to Milan, Italy, to perform scientific research on a grant from the Italian Council of Science. Later, Dr.
Stelzner completed a research fellowship at the National Institutes of Health (NIH) for the Harvard
Medical School/Brigham and Women’s Hospital. She is a sought-after speaker at national ophthalmology
conventions and internationally, including a recent trip to speak at several hospitals in Japan. Twice every
year, she has taught cataract surgery courses to ophthalmology residents from UCLA, USC, UCI, UCSD,
and Loma Linda. Charitable by nature, Dr. Stelzner often gives back to her local and global communities.
She is a regular volunteer at local high schools, providing eye care to students and their families. Dr.
Stelzner has even traveled as part of a humanitarian team to Mexico and El Salvador, performed
sight-restoring surgeries, and taught local eye physicians her safe and innovative eye surgery techniques.
She has also traveled to Japan to share her world-renowned surgical techniques. Dr. Stelzner holds active
memberships with various associations, such as the American Academy of Ophthalmology, American
College of Surgeons, American Society of Cataract and Refractive Surgery, American Medical
Association, California Medical Association, and the American Society of Anti-Aging. As an
award-winning ophthalmologist, she has received Doctors’ Choice Award, Super Doctor voted by the
medical peers of Los Angeles Magazine and Los Angeles Times, Best Teaching Award from the Jules
Stein Eye Institute/UCLA, and Voted Patients’ Choice on Vital and Hotwire.com. Avocationally, she
enjoys traveling, hiking, yoga, and cooking.

Page 1 of 3
PR.com Press Release Distribution Terms
Contact Information:
Top 100 Registry Inc.
David Lerner
855-785-2514
Contact via Email
www.top100registry.com

Online Version of Press Release:


https://www.pr.com/press-release/855697

Page 2 of 3
PR.com Press Release Distribution Terms
Page 3 of 3
PR.com Press Release Distribution Terms

You might also like